Concepedia

Vishal Kumar Vishwakarma

VK

5

Publications

128

Citations

5

H-Index

2017

Active since

Affiliations

All India Institute of Medical Sciences(Current)

GLA University

Institute of Nano Science and Technology

Vishal Kumar Vishwakarma is an author at All India Institute of Medical Sciences specializing in pharmacology, medicine, and nanomedicine.

ORCID

Top concepts

Publications per year

2017–2023

5

Publications

5

PHARMACOLOGICAL IMPORTANCE OF CUCUMIS MELO L.: AN OVERVIEW

Vishal Kumar Vishwakarma, Jeetendra Kumar Gupta, Prabhat Kumar Upadhyay · Asian Journal of Pharmaceutical and Clinical Research · 2017 · 52 citations · Full text

, , +21

Fat fighting liraglutide based nano-formulation to reverse obesity: Design, development and animal trials

Vishal Kumar Vishwakarma, Raghuraj Singh, Krishna Jadhav et al. · International Journal of Pharmaceutics · 2023 · 29 citations

, , +5

Orally deliverable nanoformulation of liraglutide against type 2 diabetic rat model

N. Senduran, Harlokesh Narayan Yadav, Vishal Kumar Vishwakarma et al. · Journal of Drug Delivery Science and Technology · 2020 · 22 citations

, , +10

Pain Allaying Epalrestat-Loaded Lipid Nanoformulation for the Diabetic NeuropathicPain Interventions: Design, Development, and Animal Study

Vishal Kumar Vishwakarma, Shravan Kumar Paswan, Taruna Arora et al. · Current Drug Metabolism · 2022 · 14 citations

The ceiling effect of curcumin and quercetin in combination on cyclophosphamide induced hepatotoxicity

Manoj Kumar Yadav, Jayesh Dwivedi, Prabhat Kumar Upadhyay et al. · Annals of Phytomedicine An International Journal · 2021 · 11 citations · Full text

Rows per page

1–5 of 5